NCATS director: Taken together, rare diseases are not uncommon | Dabigatran may not curb post-cryptogenic stroke recurrence | Study links glycemic control, diabetes duration to fracture risk
May 17, 2019
CONNECT WITH ANA  LinkedInFacebookTwitter
ANA SmartBrief
News for the nursing profession
SIGN UP ⋅   FORWARD
Top Story
NCATS director: Taken together, rare diseases are not uncommon
About 8% of people have a rare disease, which is comparable to how many people have type 2 diabetes, but their needs are invisible to policymakers, and the introduction of new treatments needs to be dramatically accelerated, said Christopher Austin, director of the National Center for Advancing Translational Sciences. "We at NCATS have decided that we have real problems with the word 'rare,'" Austin said.
Hemophilia News Today (5/15) 
LinkedIn Twitter Facebook Email
Nursing, Health & Medical Science
Dabigatran may not curb post-cryptogenic stroke recurrence
Individuals with recent embolic stroke of an unknown source who received dabigatran had similar rates of recurrent strokes and ischemic strokes, compared with those who were given aspirin, researchers reported in The New England Journal of Medicine. The findings also showed similar odds of major bleeding in both groups, but clinically relevant minor bleeds were more prevalent among those in the dabigatran group.
MedPage Today (free registration) (5/16) 
LinkedIn Twitter Facebook Email
Study links glycemic control, diabetes duration to fracture risk
Patients with type 1 diabetes who had an A1C level of 7.9% were 3.5 times more likely to have multiple fractures than those whose A1C levels were less than 7.2%, according to a study in the journal Bone. Italian researchers analyzed data from 600 diabetes patients, mean age of 42, and found that those who had diabetes for 26 years were 7.5 times more likely to experience multiple fractures, compared with patients who had diabetes for less than 14 years.
Healio (free registration)/Endocrine Today (5/14) 
LinkedIn Twitter Facebook Email
Drug promising in treating tumors with gene fusions in youths
All children with tumors that have ALK, ROS1 or NTRK1/2/3 gene fusions or ALK mutations who received entrectinib, an investigational tyrosine kinase inhibitor, had "rapid and durable" treatment response, according to a study to be presented at the American Society of Clinical Oncology's annual meeting. "Although the target fusions are rare and the chances of finding the fusion may be low, clinicians should be looking for these gene aberrations because the impact of therapy is very promising -- especially when alternative treatment options are limited," said researcher Giles Robinson.
Healio (free registration)/HemOnc Today (5/16) 
LinkedIn Twitter Facebook Email
Diagnostic tests, instruments for blood clot monitoring compared
Investigators compared tests and instruments for monitoring blood clots during surgery and other procedures and reported in the journal Lab Medicine that the Abbott iStat test performed best and was affected less by factors such as temperature, fibrinogen levels and dilution. Researchers had no vested interest in any of the tools, senior author Gurmukh Singh said.
360Dx (tiered subscription model) (5/16) 
LinkedIn Twitter Facebook Email
Brain receptor may be linked to suicidal thoughts in PTSD patients
Higher levels of the brain receptor mGluR5 on the surface of brain cells may be linked to suicidal thoughts in patients with post-traumatic stress disorder, according to findings published in Proceedings of the National Academy of Sciences. The brains of people with PTSD who indicated they'd had suicidal thoughts the day of their scans showed higher levels of mGluR5 than the brains of people in a control group, researchers say.
LiveScience (5/16) 
LinkedIn Twitter Facebook Email
Trends & Technologies
Survey: Most health insurance providers offer virtual care
A survey released by America's Health Insurance Plans found most commercial, Medicare Advantage and managed Medicaid health insurance providers are already offering some type of virtual care, and they report benefits including improved health outcomes, increased patient satisfaction and better access to care. Most commercial and Medicaid managed care providers, however, said patient engagement remains a barrier to full adoption of virtual care.
Healthcare Dive (5/16) 
LinkedIn Twitter Facebook Email
Hospice's virtual reality tool helps patients live out their dreams
Virtual reality may be a way to help hospice patients complete the experiences they've always hoped to have, and Laurie McKay, Continuum Care Hospice's chief nursing educator, helped a man with terminal cancer and his wife do just that. Illness stopped the couple from taking a cruise they planned, so McKay mapped out all the ports on the cruise, and gave them 360-degree views of the sights they would have seen in person.
CNET (5/16) 
LinkedIn Twitter Facebook Email
Hypoglycemia tied to lower QOL, poor psychological health in diabetes
Italian researchers found a lower quality of life, more diabetes distress, fear of hypoglycemia, and poorer general and psychological health among patients with type 1 and type 2 diabetes who experienced a severe hypoglycemic event in the previous year, compared with those without such events. The findings in Nutrition, Metabolism and Cardiovascular Diseases, based on 2,229 adults, revealed that a score of more than 25 on the fear of hypoglycemia questionnaire was more likely among women, insulin users, those who had severe hypoglycemia and those who had at least a high school education.
Healio (free registration)/Endocrine Today (5/14) 
LinkedIn Twitter Facebook Email
Legislative Policy & Regulatory News
Dalteparin approved for venous thromboembolism in children
Pfizer's Fragmin, or dalteparin sodium, was approved by the FDA to lessen the recurrence of symptomatic venous thromboembolism in pediatric patients at least 1 month old. The drug was first approved for adult patients with certain types of angina, deep vein thrombosis and symptomatic VTE.
eMPR (5/16) 
LinkedIn Twitter Facebook Email
ANA News
A certified nurse can improve patient outcomes
A certified nurse can improve patient outcomes
Help build your nursing staff's confidence and add value to your organization. Learn about our new course design and the benefits of hosting a workshop.
LinkedIn Twitter Facebook Email
 
Learn more about ANA:
Join ANA | My ANA | NursingWorld.org
NursesBooks.org | Conferences | ANA Career Center
JOBS
powered by
Registered Nurse Medical Surgical arena (No new graduates)
BARBARICUM - Washington, Dist. Columbia
  
  
Give credit where credit is due: simply said, if you want loyalty and best effort, you must be thoughtful.
Estee Lauder,
businesswoman

May is Jewish American Heritage Month

LinkedIn Twitter Facebook Email
  
  
The news reported in ANA SmartBrief does not necessarily reflect the official opinion of ANA. Some links in ANA SmartBrief are time-sensitive, and may move or expire over time. Some sources also may require registration or fee-based subscriptions.
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Molly Ufheil
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2019 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information